Thomas Leggett, Chief Financial Officer at Black Diamond Therapeutics, Inc. (BDTX), sold 3,000 shares at $31.00 ($93K) on 2020-09-14, disclosed to the SEC on 2020-09-16.
Open-market sale of $93k BDTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BDTX | SELL | 2020-12-10 | $167K | — | Filing → |
| BDTX | SELL | 2020-11-12 | $99K | — | Filing → |
| BDTX | SELL | 2020-10-09 | $101K | — | Filing → |